A double‐blind, randomized, placebo‐controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing‐remitting multiple sclerosis
Fox, Robert J., Wiendl, Heinz, Wolf, Christian, De Stefano, Nicola, Sellner, Johann, Gryb, Viktoriia, Rejdak, Konrad, Bozhinov, Plamen Stoyanov, Tomakh, Nataliya, Skrypchenko, Iryna, Muehler, Andreas R.
Published in Annals of clinical and translational neurology (01.07.2022)
Published in Annals of clinical and translational neurology (01.07.2022)
Get full text
Journal Article
Safety, Tolerability, and Pharmacokinetics of IMU‐935, a Novel Inverse Agonist of Retinoic Acid Receptor–Related Orphan Nuclear Receptor γt: Results From a Double‐Blind, Placebo‐Controlled, First‐in‐Human Phase 1 Study
Polasek, Thomas M., Leelasena, Indika, Betscheider, Irina, Marolt, Marija, Kohlhof, Hella, Vitt, Daniel, Fliegert, Frank, Muehler, Andreas R.
Published in Clinical pharmacology in drug development (01.05.2023)
Published in Clinical pharmacology in drug development (01.05.2023)
Get full text
Journal Article
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial
Fox, Robert J, Wiendl, Heinz, Wolf, Christian, De Stefano, Nicola, Sellner, Johann, Gryb, Viktoriia, Rejdak, Konrad, Bozhinov, Plamen S, Vitt, Daniel, Kohlhof, Hella, Slizgi, Jason, Ondrus, Matej, Sciacca, Valentina, Muehler, Andreas R
Published in Neurology : neuroimmunology & neuroinflammation (01.05.2024)
Published in Neurology : neuroimmunology & neuroinflammation (01.05.2024)
Get full text
Journal Article
Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Vehreschild, Maria J. G. T., Atanasov, Petar, Yurko, Kateryna, Oancea, Cristian, Popov, Georgi, Smesnoi, Valentina, Placinta, Gheorghe, Kohlhof, Hella, Vitt, Daniel, Peelen, Evelyn, Mihajlović, Jelena, Muehler, Andreas R.
Published in Infectious diseases and therapy (01.12.2022)
Published in Infectious diseases and therapy (01.12.2022)
Get full text
Journal Article